011sek
-6,8 %
Date:2025-04-25Time:18:00:00Latest report:Q4-2024List:First NorthTicker:LPGO
Market Cap:16 msekEnterprise Value:4 msekNet Sales:10,3 msekEarnings:-25,3 msekEmployees:0ISIN:SE0015382072

Ratios

10-year key figure history for Lipigon Pharmaceuticals turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Lipigon Pharmaceuticals with index and moving average MA50 and MA200.

Stockprice:0,11
MA50:0,15
MA200:0,20
Price/MA200:-46,2 %
RSI (14):40,9
Price/MA50:-28,6 %

Description

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Pharmaceuticals